Clinical Trial Update: Safety, Tolerability, and Efficacy of Deferasirox in MDS [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety, tolerability, and efficacy of deferasirox in myelodysplastic syndromes, focusing on iron chelation in patients with iron overlo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemosiderosis
• Myelodysplastic Syndromes

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Myelodysplastic Syndromes, Hemosiderosis | Phase 3 | Status: COMPLETED